FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

Article excerpt

The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F. Kennedy Jr.